• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time.

作者信息

Cattaneo Chiara, Pagani Chiara, Cancelli Valeria, Imberti Luisa, Roccaro Aldo M, Notarangelo Luigi D, Rossi Giuseppe

机构信息

Department of Haematology, ASST Spedali Civili, Brescia, Italy.

CREA Laboratory (AIL Center for Hemato-Oncologic Research), ASST Spedali Civili, Brescia, Italy.

出版信息

Leukemia. 2021 Feb;35(2):632-634. doi: 10.1038/s41375-020-01015-1. Epub 2020 Aug 7.

DOI:10.1038/s41375-020-01015-1
PMID:32770087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7412768/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf99/7412768/9cd673e36119/41375_2020_1015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf99/7412768/9cd673e36119/41375_2020_1015_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf99/7412768/9cd673e36119/41375_2020_1015_Fig1_HTML.jpg

相似文献

1
Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time.随着时间推移，血液学患者中新冠病毒病（COVID-19）的发病率降低，预后改善。
Leukemia. 2021 Feb;35(2):632-634. doi: 10.1038/s41375-020-01015-1. Epub 2020 Aug 7.
2
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.来自印度血液癌症登记处的血液系统恶性肿瘤患者与新冠病毒病的治疗结果。
Blood Cancer J. 2022 Jan 5;12(1):2. doi: 10.1038/s41408-021-00599-w.
3
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.英国一家大型城市医疗信托机构中血液系统恶性肿瘤合并新型冠状病毒肺炎感染住院患者的结局
Leuk Lymphoma. 2021 Feb;62(2):469-472. doi: 10.1080/10428194.2020.1838506. Epub 2020 Nov 9.
4
Impact of Covid19 on a tertiary care pediatric oncology and stem cell transplant unit in Riyadh, Saudi Arabia.新型冠状病毒肺炎对沙特阿拉伯利雅得一家三级医疗儿科肿瘤与干细胞移植科室的影响。
Pediatr Blood Cancer. 2020 Sep;67(9):e28560. doi: 10.1002/pbc.28560. Epub 2020 Jul 12.
5
The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.COVID-19 大流行对现实中血液学环境的直接和间接影响。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1358. doi: 10.1002/cnr2.1358. Epub 2021 Mar 3.
6
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey.COVID-19 与干细胞移植：来自 EBMT 和 GETH 多中心前瞻性调查的结果。
Leukemia. 2021 Oct;35(10):2885-2894. doi: 10.1038/s41375-021-01302-5. Epub 2021 Jun 2.
7
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.癌症患者感染 COVID-19 后的死亡风险：来自伦敦盖伊癌症中心和国王学院医院的分析。
Br J Cancer. 2021 Sep;125(7):939-947. doi: 10.1038/s41416-021-01500-z. Epub 2021 Aug 16.
8
Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany.德国综合癌症中心中合并新型冠状病毒肺炎的多发性骨髓瘤患者的临床特征及预后
Haematologica. 2020 Dec 1;105(12):2872-2878. doi: 10.3324/haematol.2020.262758.
9
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.COVID-19 感染血液系统疾病患者的临床特征和死亡风险因素。
Cancer. 2020 Dec 1;126(23):5069-5076. doi: 10.1002/cncr.33160. Epub 2020 Sep 10.
10
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.血液系统恶性肿瘤合并 COVID-19 患者的结局：对 3377 例患者的系统评价和荟萃分析。
Blood. 2020 Dec 17;136(25):2881-2892. doi: 10.1182/blood.2020008824.

引用本文的文献

1
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors.肝移植受者对多剂新冠疫苗的高抗体反应率：预测因素分析
Vaccines (Basel). 2025 Mar 26;13(4):352. doi: 10.3390/vaccines13040352.
2
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.血液系统恶性肿瘤与新冠同时发病：一项Epicovideha调查
Cancers (Basel). 2022 Nov 10;14(22):5530. doi: 10.3390/cancers14225530.
3
High mortality in fully vaccinated hematologic patients treated with anti-CD20 antibodies during the "Omicron wave" of COVID-19 pandemic.

本文引用的文献

1
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.来特莫韦在未上市药品适应证中的应用：欧洲血液和骨髓移植学会传染病工作小组的回顾性研究。
Bone Marrow Transplant. 2021 May;56(5):1171-1179. doi: 10.1038/s41409-020-01166-w. Epub 2020 Dec 7.
2
Complete, yet partial: the benefits of complete response with partial haematological recovery as an endpoint in acute myeloid leukaemia clinical trials.
Lancet Haematol. 2020 Dec;7(12):853-856. doi: 10.1016/S2352-3026(20)30352-5.
3
Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.吞噬和细胞迁移蛋白 1（ELMO1）和载脂蛋白 A1（APOA1）作为镰状细胞肾病的候选基因。
在新冠疫情“奥密克戎浪潮”期间，接受抗CD20抗体治疗的血液学患者中，完全接种疫苗者死亡率较高。
Hematol Oncol. 2023 Feb;41(1):205-207. doi: 10.1002/hon.3064. Epub 2022 Aug 19.
4
Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.BNT162b2 mRNA新冠疫苗在慢性淋巴细胞白血病患者中的安全性和免疫原性：一项前瞻性研究
Ther Adv Hematol. 2022 May 23;13:20406207221090150. doi: 10.1177/20406207221090150. eCollection 2022.
Br J Haematol. 2021 May;193(3):628-632. doi: 10.1111/bjh.17224. Epub 2020 Nov 20.
4
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.24 个月无进展生存和随后生存的患者结外 NK/T 细胞淋巴瘤：中国淋巴瘤协作组（CLCG）研究。
Leukemia. 2021 Jun;35(6):1671-1682. doi: 10.1038/s41375-020-01042-y. Epub 2020 Sep 17.
5
PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2-Mutant MPN.PRMT5 抑制作用调节 E2F1 甲基化和基因调控网络，从而提高 JAK2 突变型 MPN 的治疗效果。
Cancer Discov. 2020 Nov;10(11):1742-1757. doi: 10.1158/2159-8290.CD-20-0026. Epub 2020 Jul 15.
6
Impact of Covid-19 on the treatment of acute myeloid leukemia.新冠疫情对急性髓系白血病治疗的影响。
Leukemia. 2020 Aug;34(8):2254-2256. doi: 10.1038/s41375-020-0925-7. Epub 2020 Jun 19.
7
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.新冠病毒病与血液系统恶性肿瘤并存的住院患者生存研究
Br J Haematol. 2020 Jul;190(1):e16-e20. doi: 10.1111/bjh.16801. Epub 2020 May 27.
8
COVID-19 outcomes in patients with hematologic disease.血液系统疾病患者的新型冠状病毒肺炎结局
Bone Marrow Transplant. 2020 Nov;55(11):2180-2184. doi: 10.1038/s41409-020-0931-4. Epub 2020 May 6.